BioTwin gives clinicians novel longitudinal information about their patients' biology, behavior, and history to support earlier conversations and better-targeted decisions.
Availability by region: BioTwin cancer screening decision assistance is available only through participating physicians in authorized UAE clinical settings. Canada is pending Health Canada review. The United States is pending FDA review. Do not use BioTwin clinical outputs for patient care in jurisdictions where authorization has not been granted.
What BioTwin is, and what it is not
A virtual twin does not replace a clinician. A virtual twin is there to assist clinicians in making better-informed decisions. BioTwin is not and never will be an expert in oncology, neurology, or cardiology. BioTwin's role is to provide the data infrastructure that lets the experts do their best work, by giving them novel longitudinal information they do not otherwise have access to.
Where BioTwin is approved
UAEUAE: available through participating physicians in authorized clinical settings for breast and colorectal cancer screening decision assistance.
CanadaCanada: pending Health Canada review. Not commercially available for clinical screening decision assistance.
United StatesUnited States: pending FDA review. Not commercially available for clinical screening decision assistance.
Health condition roadmap
Roadmap items describe regulated clinical development priorities, not current commercial availability outside authorized settings.
BioTwin is building its clinical roadmap in stages, with oncology first, cardiology second, and neurology third.
Top priority
Oncology
Breast cancer
Colorectal cancer
Lung cancer
Pancreatic cancer
Prostate cancer
Ovarian cancer
Second priority
Cardiology
Hypertension
Heart failure
Third priority
Neurology
Parkinson's disease
Alzheimer's disease
Epilepsy
Major depressive disorder
The clinical role of the virtual twin
Earlier and better-targeted screening conversations
Longitudinal monitoring across repeated samples
A discussion-ready summary for the clinician's decision-making
